Literature DB >> 8061653

Production and cross-reactivity patterns of a panel of high affinity monoclonal antibodies to Vibrio cholerae O139 Bengal.

S Garg1, T Ramamurthy, A K Mukhopadhyay, B C Deb, G B Nair, T Shimada, T Takeda, A Huq, R R Colwell, Y Takeda.   

Abstract

A series of monoclonal antibodies of different isotypes specific for Vibrio cholerae O139, the new pandemic strain of cholera, was produced. These mAbs reacted only with the reference strain (MO45) representing serovar O139 but did not react with any of the other reference strains representing serovars O1 to O140. Significantly, the mAbs did not agglutinate the R-cultures of V. cholerae (CA385, 20-93) which demonstrated the exceptional specificity of these mAbs and indicated that the mAbs recognized antigenic determinants unique for the O139 serovar. There was heterogeneity in the intensity of reactivity of the mAbs with strains of V. cholerae O139 isolated from diverse sources. Apart from 4H6, the other mAbs agglutinated all the O139 strains examined. 2D12 and 2F8 were the best mAbs based on the intensity of agglutination with all the O139 strains. Evaluation of 3A10 in comparison with a polyclonal anti-O139 antibody raised in rabbit using the slide agglutination format revealed that 3A10 fared as well as the polyclonal antibody for the laboratory identification of the O139 serovar. The acquisition of these mAbs provide reagents which would be very useful in the development of simple immunodiagnostic assays for the diagnosis of V. cholerae O139 infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061653     DOI: 10.1111/j.1574-695X.1994.tb00455.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Molecular characterization of high-level-cholera-toxin-producing El Tor variant Vibrio cholerae strains in the Zanzibar Archipelago of Tanzania.

Authors:  A Naha; G Chowdhury; J Ghosh-Banerjee; M Senoh; T Takahashi; B Ley; K Thriemer; J Deen; L V Seidlein; S M Ali; A Khatib; T Ramamurthy; R K Nandy; G B Nair; Y Takeda; A K Mukhopadhyay
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

2.  Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis.

Authors:  A K Mukhopadhyay; S Garg; R Mitra; A Basu; K Rajendran; D Dutta; S K Bhattacharya; T Shimada; T Takeda; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.

Authors:  C Sharma; M Thungapathra; A Ghosh; A K Mukhopadhyay; A Basu; R Mitra; I Basu; S K Bhattacharya; T Shimada; T Ramamurthy; T Takeda; S Yamasaki; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

4.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

5.  Development and testing of monoclonal antibody-based rapid immunodiagnostic test kits for direct detection of Vibrio cholerae O139 synonym Bengal.

Authors:  J A Hasan; A Huq; G B Nair; S Garg; A K Mukhopadhyay; L Loomis; D Bernstein; R R Colwell
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

6.  Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup.

Authors:  A K Mukhopadhyay; S Garg; G B Nair; S Kar; R K Ghosh; S Pajni; A Ghosh; T Shimada; T Takeda; Y Takeda
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

7.  Phenotypic and Genetic Heterogeneity in Vibrio cholerae O139 Isolated from Cholera Cases in Delhi, India during 2001-2006.

Authors:  Raikamal Ghosh; Naresh C Sharma; Kalpataru Halder; Rupak K Bhadra; Goutam Chowdhury; Gururaja P Pazhani; Sumio Shinoda; Asish K Mukhopadhyay; G Balakrish Nair; Thadavarayan Ramamurthy
Journal:  Front Microbiol       Date:  2016-08-09       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.